Hypnotic Discontinuation in Chronic Insomnia
Authors:
- 20 September 2022
- journal article
- research article
- Published by Elsevier in Sleep Medicine Clinics
- Vol. 17 (3) , 523-530
Abstract
No abstract availableKeywords
Funding Information
- Philips
- Merck
This publication has 62 references indexed in Scilit:
- A Review of the Use of Clonidine as a Sleep Aid in the Child and Adolescent PopulationClinical Pediatrics, 2013
- Analysis of benzodiazepine withdrawal program managed by primary care nurses in SpainBMC Research Notes, 2012
- Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription databaseExpert Opinion on Pharmacotherapy, 2011
- How Is Medication Prescribing Ceased?Medical Care, 2011
- Discontinuation of hypnotics during cognitive behavioural therapy for insomniaBMC Psychiatry, 2008
- Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: a double‐blind randomized clinical trialAddiction, 2007
- Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trialPharmacy World & Science, 2007
- Clinical application of paroxetine for tapering benzodiazepine use in non‐major‐depressive outpatients visiting an internal medicine clinicPsychiatry and Clinical Neurosciences, 2006
- Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled studyEuropean Neuropsychopharmacology, 2004
- Imipramine and Buspirone in Treatment of Patients With Generalized Anxiety Disorder Who Are Discontinuing Long-Term Benzodiazepine TherapyAmerican Journal of Psychiatry, 2000